Skip to Content

GS WXG (Requip XL 4 mg)

Generic Name: ropinirole

Pill with imprint GS WXG is Brown, Elliptical / Oval and has been identified as Requip XL 4 mg. It is supplied by GlaxoSmithKline.

Requip XL is used in the treatment of periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Requip XL 4 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GS WXG

Requip XL

Generic Name:
ropinirole
Imprint:
GS WXG
Strength:
4 mg
Color:
Brown
Size:
13.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
GlaxoSmithKline
Inactive Ingredients:
carboxymethylcellulose sodium
silicon dioxide
glyceryl dibehenate
hydrogenated castor oil
hypromelloses
lactose monohydrate
magnesium stearate
maltodextrin
mannitol
povidone
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide